We are thrilled to announce #NDLR2026 speaker Dr Cavan Bennett postdoctoral researcher @wehi-research.bsky.social. Cavan's research focuses on #haematology particular the effects of iron in #MyeloproliferativeNeoplasms. #BloodCancer #CancerResearch

We are excited to announce #NDLR2026 speaker Chelsea Mayho from the Children's Cancer Institute. Chelsea is working on developing #Bioinformatics pipelines for the #ZeroChildhoodCancer Program #ClinicalTrials, including the development of a #DrugDiscovery pipeline. #Leukemia

We are excited to announce #NDLR2026 speaker Dr Raymond Yip from @wehi-research.bsky.social. Raymond’s current #CancerResearch focus is on the implementation of novel spatial #Omics to understand the bone microenvironment in #MultipleMyeloma.

We are thrilled to announce #NDLR2026 speaker Dr Julie Thoms, from UNSW . Julie's research interests lie in understanding #GeneRegulation in #Leukemia driving stem cells to develop #TargetedTherapies. #BloodCancer #CancerResearch #MyelodysplasticSyndromes #AcuteMyeloidLeukemia

We are excited to announce #NDLR2026 speaker Prof Hamish Scott, from SA Pathology. Hamish's #CancerResearch is on identifying #BloodCancer #Genetics for the use in #PersonalizedMedicine.

🚨 Call for Abstracts Now Open #NDLR2026 🚨 Only 1 week left to submit your abstracts! 🗓 Abstract submission closes 23 September 2025 🩸 Submit now: www.ndlr.org.au #BloodCancer #CancerResearch #ChildhoodCancer

We are excited to announce #NDLR2026 speaker, Assoc Prof @LevKats from @PeterMacCC. Lev's research includes #Epigenetic regulation, #Metabolism and #TargetedTherapies. His lab uses molecular and functional #Genomics to develop new treatment strategies for aggressive #BloodCancers

We are excited to announce our new #NDLR2026 Meet-the-Editor session, with Editors-in-Chief, Prof Andrew Roberts, @bloodjournals.hematology.org and Prof @jancools.bsky.social, @hemasphere-journal.bsky.social who will share their invaluable insights on #publishing in high-impact #hematology journals.

We are thrilled to announce Prof @elizahawkes.bsky.social Hawkes, the Chief Clinical Research Officer at the Olivia Newton-John Cancer Research Institute and #Lymphoma doc at Austin Health, as a speaker at #NDLR2026. Eliza’s interests are implementing novel #CancerTherapies into #ClinicalTrails.

We are excited to announce #NDLR2026 speaker, clinician-scientist Prof Rishi Kotecha from the Kids Research Institute. His research aims to develop novel #CancerTherapies for #ChildhoodCancer. He is also leading #ClinicalTrails to improve outcomes for children with #Leukemia.

We are excited to introduce #NDLR2026 speaker Dr Jennifer Devlin, one of from @petermaccc.bsky.social. Jennifer’s research focuses on dissecting the molecular mechanisms that control #GeneExpression to identify transcriptional vulnerabilities that may be exploited for #CancerTreatment.

We are honoured to welcome clinician-scientist Prof Steven Lane from @qimrb.bsky.social as a speaker to #NDLR2026. Steven’s research concentrates on understanding how #leukemia stem cells in #AcuteMyeloidLeukemia and #MyeloproliferativeNeoplasm can regenerate leukemia.

We are thrilled to announce that Associate Professor @juliamaxson.bsky.social from @ohsuknight.bsky.social, USA, will be joining us at #NDLR2026. Julia's research focuses on investigating the cellular and molecular changes that cause myeloid #Leukemia.

🚨 Call for Abstracts Now Open #NDLR2026 🚨 Only 3 weeks left to submit your abstracts! 🗓 Abstract submission closes 23 September 2025 🩸 Submit now: www.ndlr.org.au 🎟️ Earlybird Registration is now open – secure your spot today! #BloodCancer #CancerResearch #ChildhoodCancer

🚨 Call for Abstracts Now Open – #NDLR2026 🚨 🗓 Abstract submission closes 23 September 2025 🧬 Submit now: www.ndlr.org.au Plus, Earlybird Registration is now open – secure your spot today! #BloodCancer #CancerResearch #ChildhoodCancer

We are honoured to welcome Professor John D. Crispino, from @stjude.bsky.social as speaker to #NDLR2026. John’s research focuses on mechanisms of #Leukemia development in children with Down syndrome and the malignant progression of #MyelodysplasticSyndrome and #MyeloproliferativeNeoplasms.

We are excited to announce that Dr Elliot Stieglitz will be joining us at NDLR 2026. Hope to see you there. #NDLR2026. #leukaemia #bloodcancer #cancer #research

We are happy to announce that Dr Jad Othman will be coming to Adelaide for NDLR 2026. #NDLR2026 #bloodcancer.#leukaemia #research #cancer

We are pleased to announce that A/Prof Jessica Nordlund will be joining us in Adelaide at #NDLR2026. #cancer #leukaemia #research #bloodcancer

We are please to announce that Dr Lindsey Montefiori will be joining us as an invited speaker for NDLR 2026. #NDLR2026 #Leukaemia #bloodcancer #research

We are pleased to announce the first of our invited speakers for the NDLR 2026 program Prof Ari Melnick. #NDLR2026

Want to stay up to date with all things surrounding #NDLR2026? Sign up for our mailing list here: eventstudio.eventsair.com/ndlr-2026/

We are happy to announce some key dates for NDLR 2026. Hope to see you there! #NDLR2026

The Scientific and Organising Committees would like to invite you to be a part of the New Directions in Leukaemia Research (NDLR) Meeting 2026 being held in Adelaide, Australia Mon 2 March - Wed 4 March 2026.#NDLR2026